Spark Investment Management LLC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 100 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Spark Investment Management LLC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,440,000
+22.4%
65,400
-20.1%
0.17%
+12.7%
Q3 2019$1,176,000
-39.7%
81,900
-33.9%
0.15%
+11.1%
Q2 2019$1,950,000
+58.9%
123,872
+23.6%
0.14%
+87.5%
Q2 2018$1,227,000
-11.5%
100,200
-30.9%
0.07%
-19.1%
Q1 2018$1,386,000
+842.9%
145,000
+1267.9%
0.09%
+323.8%
Q2 2015$147,00010,6000.02%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$74,954,00012.68%
Aquilo Capital Management, LLC 1,237,379$22,731,0008.86%
EcoR1 Capital, LLC 3,346,301$61,472,0006.42%
RTW INVESTMENTS, LP 6,963,135$127,913,0005.51%
BRIDGER MANAGEMENT, LLC 1,679,344$30,850,0003.57%
Parkman Healthcare Partners LLC 300,805$5,526,0002.56%
ACUTA CAPITAL PARTNERS, LLC 256,500$4,712,0002.28%
Integral Health Asset Management, LLC 185,000$3,398,0001.50%
DAFNA Capital Management LLC 147,714$2,714,0001.13%
EAM Global Investors LLC 88,465$1,625,0000.95%
View complete list of DICERNA PHARMACEUTICALS INC shareholders